Online citations, reference lists, and bibliographies.
← Back to Search

Meta-analysis Of Survival After Pleurectomy Decortication Versus Extrapleural Pneumonectomy In Mesothelioma.

E. Taioli, A. Wolf, R. Flores
Published 2015 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND This comprehensive meta-analysis was conducted to answer the question as to which procedure, pleurectomy decortication (P/D) or extrapleural pneumonectomy (EPP) is more beneficial to malignant pleural mesothelioma patients' outcome. METHODS Original research studies that evaluated long-term outcomes of P/D versus EPP were identified, from January 1990 to January 2014. The combined percent perioperative and 2-year mortality, and median survival were calculated according to both a fixed and a random effect model. The Q statistics and I(2) statistic were used to test for heterogeneity between the studies. RESULTS There were 24 distinct data sets, for a total of 1,512 patients treated with P/D, and 1,391 treated with EPP. There was a significantly higher proportion of short-term deaths in the EPP group versus the P/D group (percent mortality meta estimate; 4.5% vs 1.7%; p < 0.05). There was no statistically significant difference in 2-year mortality between the 2 groups, but there was significant heterogeneity. CONCLUSIONS The reanalysis of the large number of studies comparing P/D to EPP suggests that P/D is associated with a 2 ½-fold lower short-term mortality (perioperatively and within 30 days) than EPP. Pleurectomy decortication should therefore be preferred when technically feasible.
This paper references
10.1016/J.BRACHY.2004.11.003
A pilot trial of high-dose-rate intraoperative radiation therapy for malignant pleural mesothelioma.
K. Rosenzweig (2005)
10.1136/bmj.39343.408449.80
Uncertainty in heterogeneity estimates in meta-analyses
J. Ioannidis (2007)
How should we treat malignant pleural mesothelioma (MPM)? Acta Chir Hung 1999;38:87–90
L Lampl (1999)
10.1200/JCO.2008.19.8523
Malignant pleural mesothelioma.
A. Tsao (2009)
10.1016/S0003-4975(98)00799-1
Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up.
T. L. Moskal (1998)
10.1097/JTO.0b013e31824ab6c5
Pleurectomy/Decortication is Superior to Extrapleural Pneumonectomy in the Multimodality Management of Patients with Malignant Pleural Mesothelioma
L. Lang-Lazdunski (2012)
May cyclooxygenase2 ( COX - 2 ) , p 21 and p 27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma ?
TC Mineo (2010)
10.1016/j.ejcts.2009.07.032
Three decades of experience in the surgical multi-modality management of pleural mesothelioma.
H. Luckraz (2010)
Retro ( 2004 - 08 ) USA 19 / 9 2781 Epithelioid n
TC Mineo (2011)
10.1016/S1010-7940(03)00376-2
Treatment of mesothelioma in Bloemfontein, South Africa.
W. de Vries (2003)
10.1093/ejcts/ezu001
Surgery for malignant pleural mesothelioma: why we need controlled trials.
Tom Treasure (2014)
10.1016/S1077-9108(08)79041-8
Malignant Pleural Mesothelioma: Surgical Management in 285 Patients
P. Bejarano (2009)
10.1002/SIM.1186
Quantifying heterogeneity in a meta-analysis.
J. Higgins (2002)
10.1016/S1010-7940(02)00273-7
The management of malignant pleural mesothelioma; single centre experience in 10 years.
T. Aziz (2002)
10.1093/ejcts/ezr251
The new case for cervical mediastinoscopy in selection for radical surgery for malignant pleural mesothelioma.
A. Nakas (2012)
Longterm survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma
A Nakas (2012)
10.1007/BF02303746
Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma
H. Pass (2006)
10.1016/1010-7940(91)90142-7
Diagnostic and therapeutic strategy in malignant pleural mesothelioma.
D. Branscheid (1991)
10.1016/S1470-2045(11)70149-8
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
T. Treasure (2011)
10.1016/j.ejcts.2010.02.012
May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?
T. Mineo (2010)
How should we treat malignant pleural mesothelioma (MPM)?
L. Lampl (1999)
10.1016/j.lungcan.2013.04.024
Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma.
C. Cao (2013)
Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy.
K. Allen (1994)
10.1016/S1010-7940(02)00735-2
The management of malignant pleural mesothelioma.
G. Maggi (2003)
10.1097/JTO.0000000000000064
Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients
P. Bovolato (2014)
10.1016/j.ejcts.2007.09.044
Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
P. Borasio (2008)
10.1093/icvts/ivs465
Multimodal therapy of malignant pleural mesothelioma: is the replacement of radical surgery imminent?
J. Lindenmann (2013)
Case - control study between extrapleural pneumonectomy and radical pleurectomy / decortication for pathological N 2 malignant pleural mesothelioma
NakasA Martin-UcarAE (2007)
10.1016/j.hlc.2010.11.045
A Systematic Review of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma
C. Cao (2011)
10.1097/JTO.0b013e31815608d9
Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center
R. Flores (2007)
10.1016/j.lungcan.2011.12.009
Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure.
O. Rena (2012)
10.1093/ejcts/ezr192
Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma.
A. Nakas (2012)
10.1016/S0003-4975(99)01038-3
Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.
V. Rusch (1999)
10.1007/BF02306613
Surgically debulked malignant pleural mesothelioma: Results and prognostic factors
H. Pass (2006)
10.1155/2014/817203
Surgical Management of Malignant Pleural Mesothelioma: Impact of Surgery on Survival and Quality of Life—Relation to Chemotherapy, Radiotherapy, and Alternative Therapies
S. Papaspyros (2014)
10.1016/j.athoracsur.2011.02.062
Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma.
J. Friedberg (2011)
10.1016/J.EJCTS.2007.01.064
Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma.
A. Martin-Ucar (2007)
10.1016/j.lungcan.2013.11.026
A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.
C. Cao (2014)
10.1016/j.athoracsur.2009.01.026
Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma.
T. Yan (2009)
10.3978/j.issn.2072-1439.2013.07.40
Which type of surgery should become the preferred procedure for malignant pleural mesothelioma: extrapleural pneumonectomy or extended pleurectomy?
M. A. Bedirhan (2013)
10.1510/ICVTS.2007.166322
Radical surgery for malignant pleural mesothelioma: results and prognosis.
M. Okada (2008)
10.1562/0031-8655(2003)078<0075:ESCLIM>2.0.CO;2
Elevated Serum Cytokine Levels in Mesothelioma Patients Who Have Undergone Pleurectomy or Extrapleural Pneumonectomy and Adjuvant Intraoperative Photodynamic Therapy¶
S. S. Yom (2003)



This paper is referenced by
10.1007/978-3-319-96244-3
Caring for Patients with Mesothelioma: Principles and Guidelines
M. Hesdorffer (2019)
10.1016/j.athoracsur.2015.04.085
Reply: To PMID 25534527.
Raja M Flores (2015)
10.21037/jtd.2018.01.116
Pleurectomy/decortication versus extrapleural pneumonectomy: a critical choice.
P. Filosso (2018)
10.21037/tlcr.2020.01.08
Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma.
Gavitt A. Woodard (2020)
10.1007/978-3-030-16884-1_14
Role of Radiotherapy in Malignant Pleural Mesothelioma
Marta Scorsetti (2019)
10.1016/j.cllc.2018.08.019
Moderately Hypofractionated Helical IMRT, FDG–PET/CT‐guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs
A. Fodor (2019)
10.2217/fon.15.280
Opening lecture to the Second Mediterranean Symposium in Thoracic Oncology. Foreword.
Marcello Migliore (2015)
10.1016/j.athoracsur.2015.03.027
Personalized Aortic Root Support With Mesh Provides Optimal Valve Conservation.
C. Austin (2015)
10.21037/atm.2017.03.97
Overview of treatment related complications in malignant pleural mesothelioma.
David J Murphy (2017)
10.1016/j.jtcvs.2015.02.036
The mesothelioma enigma.
Raja M Flores (2015)
10.1093/ejcts/ezw215
Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma.
Maurizio Infante (2016)
10.1016/j.jtho.2017.08.012
National Cancer Database Report on Pneumonectomy Versus Lung‐Sparing Surgery for Malignant Pleural Mesothelioma
V. Verma (2017)
10.5761/atcs.oa.17-00192
Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience.
T. Miyazaki (2018)
10.1016/j.athoracsur.2015.02.023
Can Septic Condition or Stroke Impact on the Procalcitonin Level Along With Mesenteric Ischemia After Cardiac Surgery?
Ahmet Dolapoğlu (2015)
10.1016/j.athoracsur.2014.12.022
Improving the Exposure of the Left Hilum for Lung Transplantation: The Value of a Simple Pericardial Stitch.
Pankaj Saxena (2015)
10.5603/ARM.2019.0051
Current treatment strategies in malignant pleural mesothelioma with a treatment algorithm.
Mutlay Sayan (2019)
10.1159/000464410
Clinical Features and Treatment Outcome of Malignant Pleural Mesothelioma
M. Mencoboni (2017)
10.21037/jtd.2016.07.55
Validation of EORTC and CALGB prognostic models in surgical patients submitted to diagnostic, palliative or curative surgery for malignant pleural mesothelioma.
A. Sandri (2016)
10.1002/jso.25260
Short‐term outcomes of pleurectomy decortication and extrapleural pneumonectomy in mesothelioma
M. V. van Gerwen (2018)
10.1016/j.jtcvs.2017.11.029
Surgery for mesothelioma: Less is more, more or less.
Steven Milman (2018)
10.1016/j.jtho.2018.08.001
Surgery in Malignant Pleural Mesothelioma
R. Bueno (2018)
10.1155/2019/4568958
Dosimetric Comparison of Lung-Sparing Radiation Therapy between Volumetric Arc Therapy and Helical Tomotherapy for Unresectable Malignant Pleural Mesothelioma
Berrin Pehlivan (2019)
10.21037/jtd.2019.02.54
Pathological evaluation of the visceral pleura in the radical pleurectomy/decortication for malignant pleural mesothelioma patients.
M. Kobayashi (2019)
10.2217/LMT.15.16
Multimodality therapy for malignant pleural mesothelioma: surgery plus chemoradiotherapy?
Andrea S. Wolf (2015)
10.3389/fonc.2017.00179
Oncolytic Viral Therapy for Mesothelioma
D. Pease (2017)
10.21037/tlcr.2017.06.01
Novel systemic therapy against malignant pleural mesothelioma.
M. R. Mancuso (2017)
10.1016/j.athoracsur.2019.03.052
Disparities in Compliance with National Guidelines for the Treatment of Malignant Pleural Mesothelioma.
Fernando Espinoza-Mercado (2019)
10.1016/j.radonc.2017.08.003
The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review.
M. Ashton (2017)
10.6004/JNCCN.2016.0087
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.
D. Ettinger (2016)
10.1080/17476348.2019.1679119
Types of surgery post-neoadjuvant chemotherapy for pleural mesothelioma
Kozo Kuribayashi (2019)
10.1007/s13566-017-0299-2
Radiation therapy for localized malignant pleural mesothelioma: a propensity score-matched analysis of the National Cancer Data Base
N. Ohri (2017)
10.2147/OTT.S100214
The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma
Abdel-Ghani M. Azzouqa (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar